MEN1 and gastrin-producing neuroendocrine tumor: Among sporadic PNETs, 44% of non-functional tumors show MEN1 mutations, and the prevalence of a MEN1 mutation in functional tumors is as follows: glucagonoma (60%), VIPoma (57%), gastrinoma (38%), and insulinoma (2%–19%) (40).